Chad A. Hamilton, MD
Director, Gynecologic Oncology Service
Walter Reed National Military Medical Center
Dept. of OB/GYN
4504 Avamere Street
Bethesda,
MD
USA
20814
Papers:
11 - Focused Plenary
Molecular profiling of tumors from stage I versus stage III/IV cancer patients: a prediction signature for metastasis in Gynecologic Oncology Group 8024
41 - Featured Poster
The impact and interaction of preoperative disease burden, complex surgery, and residual disease in patients with advanced stage ovarian cancer and the effect on on patient survival: A GOG 182 analysis
43 - Featured Poster
Identification of candidate circulating cisplatin resistance biomarkers from epithelial ovarian carcinoma cell secretomes
49 - Featured Poster
Pathogenesis of ARID1A-driven gynecologic cancer
52 - Featured Poster
Pharmacologic inhibition of the DNA damage response kinases ATR (ataxia telangiectasia and rad3 related) and ATM (ataxia telangiectasia mutated) broadly sensitizes diverse subtypes of gynecologic cancer cells to ionizing radiation
60 - Scientific Plenary
Predictive model for preoperative determination of microscopic residual disease at the time of primary cytoreduction in patients with advanced-stage epithelial ovarian cancer: a Gynecologic Oncology Group (GOG) 182 analysis
98 - Featured Poster
Phase I trial results of a folate receptor alpha-directed cancer vaccine (E39) in ovarian and endometrial cancer patients to prevent recurrence
237 - Poster Session A
Clinicopathologic benchmark for prognostic modeling of advanced epithelial ovarian cancer long-term survival: a Gynecologic Oncology Group (GOG) analysis
269 - Poster Session A
Enhanced gynecologic cancer cell killing through pharmacologic inhibition of the ataxia telangiectasia and Rad3-related kinase
273 - Poster Session A
Progestin and vitamin D suppress growth of ovarian cancer in vitro and in vivo
282 - Poster Session A
Ovarian cancers with nuclear special AT-rich sequence-binding protein 1 and cytoplasmic AT-rich interactive domain-containing protein 1A are rare, drug-resistant, and deadly
295 - Poster Session A
Curated Ovarian Database-derived identification of genes predicting survival in primary serous epithelial ovarian cancer
306 - Poster Session A
Pharmacologic inhibition of polo-like kinase 1 enhances paclitaxel-based cell killing in taxol-resistant ovarian cancer cells
334 - Poster Session A
Proteomic profiling of stage I endometrial cancers: a signature of early-stage recurrence in GOG 8016
337 - Poster Session A
Proteomics of endometrial carcinogenesis: identification of candidates underlying disease pathogenesis
525 - Poster Session B
Correlation of survival-stratified proteomic and curated gene data reveal a three protein biomarker panel that predicts long-term survival of patients with primary epithelial ovarian cancer
526 - Poster Session B
Diminished survival of separated, divorced, or widowed uterine cancer patients: a potential focus for survivorship programs